FdaApplication
BLA 761412
Identifiers
- fda_app_no: BLA761412
Properties
| Property | Value |
|---|---|
| applicant_name | Sunshine Lake Pharma Co., Ltd. |
| application_type | BLA |
| approval_date | 2026-04-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LANGLARA | INSULIN GLARGINE-ALDY | 300UNITS/3ML (100UNITS/ML) | Injection |
1 product